Thousands of breast cancer patients could avoid gruelling chemotherapy thanks to research carried out by a Welsh surgeon.
Simon Holt, a breast surgeon at Hywel Dda Local Health Board, led a study into a new test to help determine whether a breast cancer patient needs to have the treatment.
The National Institute for Health and Care Excellence (NICE) has approved the 'Oncotype DX' test, which is used in people with certain types of genes and who are assessed as being at intermediate risk of their cancer spreading.
The test measures the presence of biological characteristics in the tumour which may show how likely it is to grow and whether it is likely to spread. Combined with other clinical information, the test will help determine which patients are most suitable for chemotherapy.
More top news
It will be cloudy with hill fog and mild overnight with increasing winds, with gales around southwestern coasts.
Hoping to send last minute Christmas cards and gifts? The latest dates to post them and make sure they arrive on time are fast approaching.
Thousands of cancer patients are being left in debt as they manage the cost of the disease. Here's Malcolm's story.